Publikationen, an denen er mitarbeitet Amparo Sánchez Navarro (19)

2009

  1. Vancomycin dosage optimization in patients with malignant haematological disease by pharmacokineticpharmacodynamic analysis

    Clinical Pharmacokinetics, Vol. 48, Núm. 4, pp. 273-280

2007

  1. Pharmacokinetic/pharmacodynamic analysis of vancomycin in ICU patients

    Intensive Care Medicine, Vol. 33, Núm. 2, pp. 279-285

2006

  1. Therapeutic drug monitoring of itraconazole and the relevance of pharmacokinetic interactions

    Clinical Microbiology and Infection, Vol. 12, Núm. SUPPL. 7, pp. 97-106

2005

  1. Pharmacokinetics and pharmacodynamics of levofloxacin in intensive care patients

    Clinical Pharmacokinetics, Vol. 44, Núm. 6, pp. 627-635

1997

  1. Study on pharmacokinetics and nephrotoxicity of netilmicin in rabbits using a new dosage regimen

    Methods and Findings in Experimental and Clinical Pharmacology, Vol. 19, Núm. 1, pp. 53-59

1994

  1. Comparative study of the influence of Ca2+ on absorption parameters of ciprofloxacin and ofloxacin

    Journal of Antimicrobial Chemotherapy, Vol. 34, Núm. 1, pp. 119-125

1993

  1. INTERACCION DE QUINOLONAS (1.A PARTE)

    Farmacia Clinica, Vol. 10, Núm. 5, pp. 372-392

  2. INTERACCION DE QUINOLONAS. (2.A PARTE)

    Farmacia Clinica, Vol. 10, Núm. 6, pp. 468-478

1990

  1. Effect of renal impairment on distribution of ofloxacin

    Antimicrobial Agents and Chemotherapy, Vol. 34, Núm. 3, pp. 455-459

  2. Optimization of dosage regimens of aminoglycoside antibiotics in the presence of beta-lactam agents by simulation techniques

    Acta Pharmaceutica Jugoslavica, Vol. 40, Núm. 2 SUPPL. 1, pp. 301-308

1987

  1. Effect of mode of administration on distribution of dibekacin in rabbits

    Journal of Antimicrobial Chemotherapy, Vol. 19, Núm. 6, pp. 799-806

  2. In vitro interaction between HAPA-gentamicin B and penicillins

    International Journal of Pharmaceutics, Vol. 37, Núm. 1-2, pp. 113-117

1986

  1. ESTUDIO 'IN VITRO' DE ALGUNOS FACTORES QUE MODIFICAN LA ACTIVIDAD ANTIBACTERIANA DE LA DIBECACINA

    Infectologika, Vol. 7, Núm. 4, pp. 7-10

  2. FACTORES QUE MODIFICAN LA INTERACCION HAPA-B/CARBENICILINA

    Infectologika, Vol. 7, Núm. 4, pp. 39-42

  3. INFLUENCIA DE AGENTES TENSIOACTIVOS EN LA ABSORCION GASTROINTESTINAL DE DIBECACINA

    Ciencia e Industria Farmaceutica, Vol. 5, Núm. 11, pp. 354-358

  4. In-vitro interaction between dibekacin and penicillins

    Journal of Antimicrobial Chemotherapy, Vol. 17, Núm. 1, pp. 83-89

1985

  1. FARMACOCINETICA E INDICES DE EFICACIA DE LA DIBECACINA TRAS SU ADMINISTRACION POR DIFERENTES VIAS

    Revista de Farmacologia Clinica y Experimental, Vol. 2, Núm. 4, pp. 361-366

1984

  1. Influence of dose in the urinary excretion of amikacin

    International Journal of Clinical Pharmacology Therapy and Toxicology, Vol. 22, Núm. 10, pp. 538-542

1983

  1. Amikacin concentrations in serum and blister fluid in healthy volunteers and in patients with renal impairment

    Journal of Antimicrobial Chemotherapy, Vol. 12, Núm. 5, pp. 481-488